Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Conivaptan (Primary)
- Indications Heart failure
- Focus Biomarker; Therapeutic Use
- 16 Jun 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record..
- 18 Jan 2013 New trial record